Form 4 for INSM INSMED Inc
Accepted 2024-09-10 00:00:00 ET · period of report 2024-09-06 · accession 0001628280-24-040022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-10 | 2024-09-06 | INSM | Flammer Martina M.D. | Chief Medical Off | M - OptEx | $22.77 | +149.0K | 235.7K | +172% | +$3.39M |
| DM | 2024-09-10 | 2024-09-06 | INSM | Flammer Martina M.D. | Chief Medical Off | S - Sale+OE | $71.23 | -149.0K | 115.2K | -56% | -$10.61M |
| DM | 2024-09-10 | 2024-09-06 | INSM | Flammer Martina M.D. | Chief Medical Off | M - OptEx | $0.00 | -149.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-06 | M | A | 34,280 | $26.43 | 221,583 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-06 | M | A | 18,874 | $23.66 | 187,303 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-06 | M | A | 25,740 | $26.46 | 168,429 | D | — | — | |
| 4 | Common | Common Stock | 2024-09-06 | M | A | 36,555 | $18.95 | 142,689 | D | — | — | |
| 5 | Common | Common Stock | 2024-09-06 | S | D | 9,064 | $72.61 | 106,134 | D | — | — | (F4) This is the weighted average sales price representing 9,064 shares sold at prices ranging from $72.23 to $73.07 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 6 | Common | Common Stock | 2024-09-06 | M | A | 19,423 | $17.07 | 255,136 | D | — | — | |
| 7 | Common | Common Stock | 2024-09-06 | S | D | 76,455 | $70.90 | 178,681 | D | — | — | (F2) This is the weighted average sales price representing 76,455 shares sold at prices ranging from $70.20 to $71.20 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 8 | Common | Common Stock | 2024-09-06 | S | D | 63,483 | $71.43 | 115,198 | D | — | — | (F3) This is the weighted average sales price representing 63,483 shares sold at prices ranging from $71.21 to $72.19 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 9 | Common | Common Stock | 2024-09-06 | M | A | 14,130 | $23.75 | 235,713 | D | — | — | |
| 10 | Derivative | Stock Option (right to buy) | 2024-09-06 | M | D | 19,423 | $0.00 | 84,167 | D | $17.07 · — to 2032-05-11 | 19,423 Common Stock | (F5) The options become exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| 11 | Derivative | Stock Option (right to buy) | 2024-09-06 | M | D | 34,280 | $0.00 | 34,280 | D | $26.43 · — to 2032-01-06 | 34,280 Common Stock | (F5) The options become exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| 12 | Derivative | Stock Option (right to buy) | 2024-09-06 | M | D | 18,874 | $0.00 | 0 | D | $23.66 · — to 2030-01-02 | 18,874 Common Stock | (F6) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 13 | Derivative | Stock Option (right to buy) | 2024-09-06 | M | D | 25,740 | $0.00 | 42,900 | D | $26.46 · — to 2031-05-12 | 25,740 Common Stock | (F5) The options become exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| 14 | Derivative | Stock Option (right to buy) | 2024-09-06 | M | D | 36,555 | $0.00 | 109,665 | D | $18.95 · — to 2033-05-11 | 36,555 Common Stock | (F5) The options become exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. |
| 15 | Derivative | Stock Option (right to buy) | 2024-09-06 | M | D | 14,130 | $0.00 | 0 | D | $23.75 · — to 2030-01-03 | 14,130 Common Stock | (F6) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |